Work

Radioiodine Plus Low-Dose Lenvatinib in Radioiodine-Sensitive High-Volume Metastatic Differentiated Thyroid Cancer

Year: 2025

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Nuclear Medicine

DOI: 10.1097/rlu.0000000000006146

Authors: Chandra Teja Reddy Singareddy, Chandrasekhar Bal, Swayamjeet Satapathy, Kunal Ramesh Chandekar, Sanjana Ballal, Madhavi Tripathi, Ranjit Kumar Sahoo

Institution: All India Institute of Medical Sciences

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: All-India Institute of Medical Sciences

OpenAlex ID: W4414598972

FWCI: 0.596

Cites: 24

Cited by: 1

Related to: